Cargando…

Biological activity of tumor-treating fields in preclinical glioma models

Glioblastoma is the most common and aggressive form of intrinsic brain tumor with a very poor prognosis. Thus, novel therapeutic approaches are urgently needed. Tumor-treating fields (TTFields) may represent such a novel treatment option. The aim of this study was to investigate the effects of TTFie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silginer, Manuela, Weller, Michael, Stupp, Roger, Roth, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477589/ https://www.ncbi.nlm.nih.gov/pubmed/28425987 http://dx.doi.org/10.1038/cddis.2017.171

Ejemplares similares

Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models()
por: Blomberg, Evelina, et al.
Publicado: (2022)

Programmed death ligand 1 gene silencing in murine glioma models reveals cell line-specific modulation of tumor growth in vivo
por: Blomberg, Evelina, et al.
Publicado: (2022)

CRISPR/Cas9-mediated abrogation of CD95L/CD95 signaling-induced glioma cell growth and immunosuppression increases survival in murine glioma models
por: Quijano-Rubio, Clara, et al.
Publicado: (2022)

Control of glioma cell migration and invasiveness by GDF-15
por: Codó, Paula, et al.
Publicado: (2016)

Integrin inhibition promotes atypical anoikis in glioma cells
por: Silginer, M, et al.
Publicado: (2014)

Immunological and tumor-intrinsic mechanisms mediate the synergistic growth suppression of experimental glioblastoma by radiotherapy and MET inhibition
por: Silginer, Manuela, et al.
Publicado: (2023)

Interferon-β exposure induces a fragile glioblastoma stem cell phenotype with a transcriptional profile of reduced migratory and MAPK pathway activity
por: Lohmann, Birthe, et al.
Publicado: (2020)

Tumor treating fields: a novel treatment modality and its use in brain tumors
por: Hottinger, Andreas F., et al.
Publicado: (2016)

CD95 gene deletion may reduce clonogenic growth and invasiveness of human glioblastoma cells in a CD95 ligand-independent manner
por: Quijano-Rubio, Clara, et al.
Publicado: (2022)

The role of integrins in glioma biology and anti-glioma therapies
por: Roth, Patrick
Publicado: (2015)

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02
por: Lohmann, Birthe, et al.
Publicado: (2020)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

Tumor Treating Fields in the Management of Patients with Malignant Gliomas
por: Ghiaseddin, Ashley P., et al.
Publicado: (2020)

Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
por: Segar, David J., et al.
Publicado: (2023)

Preclinical Models of Low-Grade Gliomas
por: Dasgupta, Pushan, et al.
Publicado: (2023)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023)

A RADIATION ONCOLOGIST’S EXPERIENCE TREATING MALIGNANT GLIOMA WITH TUMOR TREATING FIELDS IN CANADA
por: Roberge, David, et al.
Publicado: (2023)

Author Correction: Modeling of intracranial tumor treating fields for the treatment of complex high-grade gliomas
por: Segar, David J., et al.
Publicado: (2023)

Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
por: Crawford, John, et al.
Publicado: (2020)

Positioning Transclival Tumor-Treating Fields for the Treatment of Diffuse Intrinsic Pontine Gliomas
por: Ibn Essayed, Walid, et al.
Publicado: (2023)

Advances in radiotherapy and comprehensive treatment of high-grade glioma: immunotherapy and tumor-treating fields
por: Liu, Shiyu, et al.
Publicado: (2021)

Glioma stem cell signature predicts the prognosis and the response to tumor treating fields treatment
por: Chen, Bo, et al.
Publicado: (2022)

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy
por: Jo, Yunhui, et al.
Publicado: (2018)

DIPG-39. New preclinical models for Diffuse Midline Glioma
por: Klenner, Marbod, et al.
Publicado: (2022)

A preclinical mouse model of glioma with an alternative mechanism of telomere maintenance (ALT)
por: Jeitany, Maya, et al.
Publicado: (2015)

Delivering albumin-bound paclitaxel across the blood-brain barrier for gliomas
por: Gould, Andrew, et al.
Publicado: (2021)

Histone-Mutant Glioma: Molecular Mechanisms, Preclinical Models, and Implications for Therapy
por: Graham, Maya S., et al.
Publicado: (2020)

LS1 PRACTICAL APPLICATION AND UNDERLYING BIOLOGY OF TUMOR TREATING FIELDS
por: Bota, Daniela
Publicado: (2019)

Tumor Treating Fields: At the Crossroads Between Physics and Biology for Cancer Treatment
por: Carrieri, Francesca A., et al.
Publicado: (2020)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Monitoring Early Changes in Tumor Metabolism in Response to Therapy Using Hyperpolarized (13)C MRSI in a Preclinical Model of Glioma
por: Lim, Heeseung, et al.
Publicado: (2020)

The Biology of Malignant Mesothelioma and the Relevance of Preclinical Models
por: Blanquart, Christophe, et al.
Publicado: (2020)

Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells
por: Giladi, Moshe, et al.
Publicado: (2017)

In vivo models of brain tumors: roles of genetically engineered mouse models in understanding tumor biology and use in preclinical studies
por: Simeonova, Iva, et al.
Publicado: (2014)

Negative allosteric modulators of metabotropic glutamate receptor 3 target the stem-like phenotype of glioblastoma
por: Wirsching, Hans-Georg, et al.
Publicado: (2020)

Tumor Purity in Preclinical Mouse Tumor Models
por: Qian, Wubin, et al.
Publicado: (2022)

Is preclinical research in cancer biology reproducible enough?
por: Kane, Patrick Bodilly, et al.
Publicado: (2021)

MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape
por: Codo, Paula, et al.
Publicado: (2014)

Dexamethasone Treatment Limits Efficacy of Radiation, but Does Not Interfere With Glioma Cell Death Induced by Tumor Treating Fields
por: Linder, Benedikt, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gp0nloith4g3d4aj55ei7ssco8